Aflibercept biosimilar (Qilu Pharmaceutical) | Interleukin Related interleukin-related.com

Product Name :
Aflibercept biosimilar (Qilu Pharmaceutical)

Search keywords :
PLGF

drugId :
null

Target Vo:
Placental Growth Factor

Target Vo Short Name :
PGF

Moa_Name:
Placental Growth Factor inhibitors

First Approval Country :
Mainland China

First Approval Date Filter:
2023

Origin Company_Name :
Qilu Pharmaceutical Co Ltd

Active Company_Name :
Qilu Pharmaceutical Co Ltd

Active Indication_Name:
Macular Degeneration

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PI3 Kinase p110 gamma (Y10P59) Mouse mAb Formula
Insulin Mouse mAb Description
S1PR4 Antibody: S1PR4 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 42 kDa, targeting to S1PR4. It can be used for WB, IHC-P assays with tag free, in the background of Rat.

Author: Interleukin Related

Related Posts